Applied Psychophysiology and Biofeedback

, Volume 33, Issue 4, pp 195–201 | Cite as

A Pilot Study on the Effects of Heart Rate Variability Biofeedback in Patients with Depression and in Healthy Subjects

  • Martin SiepmannEmail author
  • Volkan Aykac
  • Jana Unterdörfer
  • Katja Petrowski
  • Michael Mueck-Weymann


Decreased vagal activity and increased sympathetic arousal have been proposed as major contributors to the increased risk of cardiovascular mortality in patients with depression. It was aim of the present study to assess the feasibility of using heart rate variability (HRV) biofeedback to treat moderate to severe depression. This was an open-label study in which 14 patients with different degrees of depression (13 f, 1 m) aged 30 years (18–47; median; range) and 12 healthy volunteers attended 6 sessions of HRV biofeedback over two weeks. Another 12 healthy subjects were observed under an active control condition. At follow up BDI was found significantly decreased (BDI 6; 2–20; median 25%–75% quartile) as compared to baseline conditions (BDI 22;15–29) in patients with depression. In addition, depressed patients had reduced anxiety, decreased heart rate and increased HRV after conduction of biofeedback (p < 0.05). By contrast, no changes were noted in healthy subjects receiving biofeedback nor in normal controls. In conclusion, HRV biofeedback appears to be a useful adjunct for the treatment of depression, associated with increases in HRV.


Heart rate variability biofeedback Effects Depression Healthy subjects Pilot study 



The present work was part of a thesis. The authors are sincerely thankful to Mrs. E. Hempel, for her assistance in conducting the study.


  1. Agelink, M. W., Boz, C., Ullrich, H., & Andrich, J. (2002). Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment. Psychological Research, 113(1–2), 139–149. doi: 10.1016/S0165-1781(02)00225-1.Google Scholar
  2. Beck, A. T., Ward, C., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.PubMedGoogle Scholar
  3. Bennaroch, E. E. (Ed.). (1997). Central autonomic network: functional organization and clinical correlations. Armonck, NY: Futura Publishing Company, Inc.Google Scholar
  4. Carney, R. M., Freedland, K. E., Miller, G. E., & Jaffe, A. S. (2002). Depression as a risk factor for cardiac mortality and morbidity. A review of potential mechanisms. Journal of Psychosomatic Research, 53, 897–902. doi: 10.1016/S0022-3999(02)00311-2.PubMedCrossRefGoogle Scholar
  5. Catipovic-Veselica, K., Galic, A., Jelik, K., et al. (2007). Relation between major and minor depression and heart rate, heart-rate variability, and clinical characteristics of patients with acute coronary syndrome. Psychological Reports, 100(3 Pt2), 1245–1254. doi: 10.2466/PR0.100.3.1245-1254.PubMedCrossRefGoogle Scholar
  6. Cohen, H., Gibson, G., & Alderman, M. H. (2000a). Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. The American Journal of Medicine, 108(1), 2–8. doi: 10.1016/S0002-9343(99)00301-0.PubMedCrossRefGoogle Scholar
  7. Cohen, H., Kotler, M., Matar, M., & Kaplan, Z. (2000b). Normalization of heart rate variability in post-traumatic stress disorder patients following fluoxetine treatment: preliminary results. The Israel Medical Association Journal, 2(4), 296–301.PubMedGoogle Scholar
  8. Del Pozo, J. M., Gevirtz, R. N., Scher, B., & Guarneri, E. (2004). Biofeedback treatment increases heart rate variability in patients with coronary artery disease. American Heart Journal, 147(3), E11. doi: 10.1016/j.ahj.2003.08.013.PubMedCrossRefGoogle Scholar
  9. Glassman, A. H., Bigger, J. T., Gaffney, M., & Van Zyl, L. T. (2007). Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement. Archives of General Psychiatry, 64(9), 1025–1031. doi: 10.1001/archpsyc.64.9.1025.PubMedCrossRefGoogle Scholar
  10. Hassett, A. L., Radvanski, D. C., Vaschillo, E. G., et al. (2007). A pilot study of the efficacy of heart rate variability (HRV) biofeedback in patients with fibromyalgia. Applied Psychophysiology and Biofeedback, 32, 1–10. doi: 10.1007/s10484-006-9028-0.PubMedCrossRefGoogle Scholar
  11. Karavidas, M. K., Leherer, P. M., Vaschillo, E., et al. (2007). Preliminary results of an open lable study of heart rate variability biofeedback for the treatment of major depression. Applied Psychophysiology and Biofeedback, 32, 19–30. doi: 10.1007/s10484-006-9029-z.PubMedCrossRefGoogle Scholar
  12. Krittayaphong, R., Cascio, W., Light, K., et al. (1997). Heart rate variability in patients with coronary artery disease: Differences in patients with higher and lower depression scores. Psychosomatic Medicine, 59, 231–235.PubMedGoogle Scholar
  13. Lehrer, P. M., Vaschillo, E., & Vaschillo, B. (2000). Resonant breathing biofeedback training to increase cardiac variability: Rationale and manual for training. Applied Psychophysiology and Biofeedback, 25(3), 177–191. doi: 10.1023/A:1009554825745.PubMedCrossRefGoogle Scholar
  14. Lehrer, P. M., Vaschillo, E., Vaschillo, B., et al. (2003). Heart rate variability biofeedback increases baroreflex gain and peak expiratory flow. Psychosomatic Medicine, 65(5), 796–805. doi: 10.1097/01.PSY.0000089200.81962.19.PubMedCrossRefGoogle Scholar
  15. McCraty, R., Atkinson, M., & Tomasino, D. (2003). Impact of a work-place stress reduction program on blood pressure and emotional health in hypertensive employees. The Journal of Complementary and Alternative Medicine, 9(3), 355–369. doi: 10.1089/107555303765551589.CrossRefGoogle Scholar
  16. Mück-Weymann, M. (2002). Die Variabilität der Herzschlagfolge - Ein globaler Indikator für Adaptivität in bio-psycho-sozialen Funktionskreisen. Praxis Klinische Verhaltensmedizin und Rehabilitation, 60, 324–330.Google Scholar
  17. Mück-Weymann, M., & Beise, R. (2005). Herzkohärenztraining – eine moderne Form der Stressbewältigung. Forum Stressmedizin, I, 1–5.Google Scholar
  18. Mück-Weymann, M., Loew, T., & Hager, D. (1996). Multiparametrisches Bio-Monitoring mit einem computerunterstützten System für psychophysiologische Diagnostik, psychophysiologisch gesteuerte Therapie und Biofeedback. Psycho, 5, 378–384.Google Scholar
  19. Mück-Weymann, M., Moesler, T., Joraschky, P., Rebensburg, M., & Agelink, M. W. (2002). Depression modulates autonomic cardiac control: A psyhopsychophysiological pathway linking depression and mortality? German Journal of Psychiatry, 5, 67–69.Google Scholar
  20. Mück-Weymann, M., & Rechlin, T. (1996). Reflexes of cutaneous microcirculation in amitriptyline and in fluoxetine treated patients. Psychopharmacology, 124(3), 241–244. doi: 10.1007/BF02246663.PubMedCrossRefGoogle Scholar
  21. Musselman, D. L., Evans, D. L., & Nemeroff, C. B. (1998). The relationship of depression to cardiovasucular disease. Epidemiology, biology and treatment. Archives of General Psychiatry, 55(7), 580–592. doi: 10.1001/archpsyc.55.7.580.PubMedCrossRefGoogle Scholar
  22. Nahshoni, E., Aravot, D., Aizenberg, D., et al. (2004). Heart rate variability in patients with major depression. Psychosomatics, 45(2), 129–134. doi: 10.1176/appi.psy.45.2.129.PubMedCrossRefGoogle Scholar
  23. Nemeroff, C. B., Musselman, D. L., & Evans, D. L. (1998). Depression and cardiac disease. Depression and Anxiety, 8(Suppl 1), 71–79. doi:10.1002/(SICI)1520-6394(1998)8:1+<71::AID-DA11>3.0.CO;2-X.CrossRefGoogle Scholar
  24. Nolan, R. P., Kamath, M. V., Floras, J. S., & Stanley, J. (2005). Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart control. American Heart Journal, 149(6), 1137. doi: 10.1016/j.ahj.2005.03.015.PubMedCrossRefGoogle Scholar
  25. Pergola, P. E., Kellogg, D. L., Jr., Johnson, J. M., et al. (1993). Role of sympathetic nerves in the vascular effects of local temperatue in human forearm skin. The American Journal of Physiology, 265(3 Pt 2), H785–H792.PubMedGoogle Scholar
  26. Rechlin, T., Weis, M., Spitzer, A., & Kaschka, W. P. (1994). Are affective disorders associated with alterations of heart rate variability? Journal of Affective Disorders, 32(4), 271–275. doi: 10.1016/0165-0327(94)90091-4.PubMedCrossRefGoogle Scholar
  27. Rissanen, A., Naukkarinen, H., Virkunnen, M., Rawlings, R. R., & Linnoila, M. (1998). Fluoxetine normalizes increased cardiac vagal tone in bulimia nervosa. Journal of Clinical Psychopharmacology, 18(1), 26–32. doi: 10.1097/00004714-199802000-00005.PubMedCrossRefGoogle Scholar
  28. Sattler, H. D., Richter, P., Fritzsche, M., von Turner, A., & Barnett, W. (2000). Neurophysiologic tests during antidepressive treatment—an exploratory study. Pharmacopsychiatry, 33(6), 229–233. doi: 10.1055/s-2000-8354.PubMedCrossRefGoogle Scholar
  29. Siepmann, M., Grossmann, J., Mück-Weymann, M., & Kirch, W. (2003). Effects of sertraline on autnomic and cognitive functions in healthy volunteers. Psychopharmacology, 168(3), 293–298. doi: 10.1007/s00213-003-1448-4.PubMedCrossRefGoogle Scholar
  30. Siepmann, M., Joraschky, P., Rebensburg, M., et al. (2005). Is autonomic cardiac control disturbed in patients with depression and coronary artery disease? Zeitschrift für Klinische Psychologie und Psychotherapie, 34(4), 277–281. doi: 10.1026/1616-3443.34.4.277.CrossRefGoogle Scholar
  31. Spielberger, C. D., Gorsuch, R. L., & Lushene, R. E. (Eds.). (1970). State-trait anxiety inventory, manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologist Press.Google Scholar
  32. Thayer, J. F., & Lane, R. D. (2000). A model of neurovisceral integration in emotion regulation and dysregulation. Journal of Affective Disorders, 61(3), 201–216. doi: 10.1016/S0165-0327(00)00338-4.PubMedCrossRefGoogle Scholar
  33. Yeragani, V. K., Rao, K. A., Smitha, M. R., Pohl, R. B., Balon, R., & Srinivasan, K. (2002). Diminished chaos of heart rate time series in patients with major depression. Biological Psychiatry, 51(9), 733–744. doi: 10.1016/S0006-3223(01)01347-6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Martin Siepmann
    • 1
    • 2
    Email author
  • Volkan Aykac
    • 2
  • Jana Unterdörfer
    • 2
  • Katja Petrowski
    • 1
  • Michael Mueck-Weymann
    • 1
    • 3
  1. 1.Clinic for Psychotherapy and Psychosomatic Medicine, Medical SchoolTechnical UniversityDresdenGermany
  2. 2.Institute of Clinical Pharmacology, Medical FacultyTechnical UniversityDresdenGermany
  3. 3.Institute of Behavioural Medicine and Prevention, Medical Informatics and TechnologyUniversity for Health SciencesHallAustria

Personalised recommendations